- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06609720
Randomized Clinical and Radiographic Study
September 23, 2024 updated by: Banan Lotfy Mohamed Amer, Tanta University
Evaluation of Autogenous Dentin Graft Versus Demineralized Freeze-Dried Bone Allograft in the Treatment of Class ΙΙ and ΙΙΙ Mandibular Furcation Defects
Randomized clinical and radiographic trial
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
Evaluation of Autogenous Dentin Graft versus Demineralized Freeze-Dried Bone Allograft in the Treatment of Class ΙΙ and ΙΙΙ Mandibular Furcation Defects
Study Type
Interventional
Enrollment (Actual)
32
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Tanta, Egypt
- Faculty of Dentistry
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
-
Presence of class II and/or ΙΙΙ furcation defects in mandibular first or second molars according to criteria outlined by Hamp et. al. 1975.
- Horizontal probing depth ≥3 mm using Naber's probe.
- Clinical attachment level ≥3 mm measured from cemento-enamel junction (CEJ) till the deepest probing depth.
- Evidence of radiolucency in the furcation area on panoramic radiograph.
- Patients who will be assigned for groups (I and II) should present with teeth required for extraction due to advanced periodontal bone loss or other indications such as hopeless wisdom teeth or orthodontic indications or unrestorable fractured teeth as a source for autogenous dentin graft (ADG).
Exclusion Criteria:
Medically compromised patients and systemic conditions precluding periodontal surgery.
- Mandibular first or second molars with root caries or endodontic treatment.
- Smokers, diabetics, pregnant or lactating women.
- History of chemotherapy, radiotherapy in head and/or neck region.
- Bisphosphonate therapy.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Group 1 subgroup A
Grade II furcation involvement treated with autogenous dentin graft
|
Randomized clinical and radiographic trial
|
|
Experimental: Group 1 Subgroup B
Grade II furcation involvement treated with demineralized freeze-dried bone allograft
|
Randomized clinical and radiographic trial
|
|
Experimental: Group II subgroup A
Grade III furcation involvement treated with Autogenous dentin graft
|
Randomized clinical and radiographic trial
|
|
Experimental: Group II subgroup B
Grade III furcation involvement treated with demineralized freeze-dried bone allograft
|
Randomized clinical and radiographic trial
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Probing pocket depth
Time Frame: Measured at baseline, 6 months and 12 months
|
According to Ramfjord, clinical parameter measured by UNC periodontal probe from a fixed point to the deepest probing depth.
Using stent to standardize the measurements.
|
Measured at baseline, 6 months and 12 months
|
|
Clinical attachment level
Time Frame: Measured at baseline, 6 months and 12 months
|
According to Ramfjord, clinical parameter measured by a Naber's probe.
Using stent to standard measurements.
|
Measured at baseline, 6 months and 12 months
|
|
Bleeding on probing
Time Frame: Measured at baseline, 6 months and 12 months
|
According to Ramfjord, the bleeding at each site observed after probing and recorded positive if bleeding was observed within 30 seconds, if not was recorded as negative.
|
Measured at baseline, 6 months and 12 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Radiographic outcome
Time Frame: measured at baseline and 1 year follow up
|
Using CBCT software to analyse furcation volume
|
measured at baseline and 1 year follow up
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Banan L Amer, Master, Tanta University
- Study Director: Samia A Darwish, Professor, Tanta University
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
March 1, 2021
Primary Completion (Actual)
December 12, 2023
Study Completion (Actual)
December 30, 2023
Study Registration Dates
First Submitted
December 5, 2023
First Submitted That Met QC Criteria
September 23, 2024
First Posted (Actual)
September 24, 2024
Study Record Updates
Last Update Posted (Actual)
September 24, 2024
Last Update Submitted That Met QC Criteria
September 23, 2024
Last Verified
February 1, 2021
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- OMPDR
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
product manufactured in and exported from the U.S.
Yes
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Autogenous Dentin Graft
-
Cairo UniversityCompletedAlveolar Ridge Preservation | Dentin Graft | Autogenous Tooth Bone GraftEgypt
-
Cairo UniversityNot yet recruitingImmediate Implant | Autogenous Tooth Graft | Estetic Zone | Autogenous Bone Graft | Jumping Gap | Crestal Bone LevelEgypt
-
Kafrelsheikh UniversityCompletedRidge Augmentation With Simultaneous Implant Placement Using Bone Blocks With Autogenous Tooth GraftImplant | Ridge Augmentation | Autogenous Tooth GraftEgypt
-
Kafrelsheikh UniversityCompletedSimvastatin | Immediate Implant Placement | Autogenous Tooth Bone GraftEgypt
-
Dalia Rasheed IssaCompletedImmediate Implant Placement | Autogenous Tooth Bone Graft | L-PRFEgypt
-
Tufts UniversityActive, not recruitingDental Implant | Bone Substitute | Maxillary Sinus Floor Augmentation | Autogenous Bone GraftUnited States
-
Ain Shams UniversityRecruitingDentin Graft, Alveolar Ridge PreservationEgypt
-
National University of MalaysiaNot yet recruitingBone Defects | Dentin Graft | Impacted Mandibular Third Molar Extraction | XenograftMalaysia
-
The Cleveland ClinicHaydarpasa Numune Training and Research HospitalWithdrawnAutogenous Bone Grafts
-
Gaziosmanpasa Research and Education HospitalUnknownNasal Deformity | Revision Rhinoplasty | Autogenous Rib Graft | Costal Cartilage | HarvestingTurkey
Clinical Trials on (guided tissue regeneration)
-
Tanta UniversityCompleted
-
BiomatlanteAtlanstatCompletedPeriodontal Bone Loss | Alveolar Bone Loss | Oral Bone Defect | Maxillofacial Bone DefectFrance
-
Postgraduate Institute of Dental Sciences RohtakPost Graduate Institute of Dental SciencesNot yet recruitingApicomarginal DefectsIndia
-
Collagen MatrixActive, not recruitingPeriodontal Diseases | Intrabony Defects | Guided Tissue RegenerationChina
-
Postgraduate Institute of Dental Sciences RohtakUnknownPeriapical LesionIndia
-
Al-Azhar UniversityCompleted
-
Tsvetalina Gerova-VatsovaCompletedVertical Alveolar Bone LossBulgaria
-
University of Turin, ItalyCompleted
-
Peking UniversityRecruitingGuided Tissue Regeneration | Extracellular Matrix Scaffold of Small Intestinal SubmucosaChina
-
University of Illinois at ChicagoRecruiting